+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Alto Neuroscience

ANRONYSE

Perks Buy Compare Brokers

$11.10

-0.3-2.63%

At Close: -

$11.10

00.00%

After Hours: 4:01 PM EDT

15 minutes delayed

Alto Neuroscience (ANRO) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Alto Neuroscience (NYSE:ANRO) Stock

Alto Neuroscience Stock (NYSE: ANRO)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, June 21, 2024

Rodman & Renshaw Initiates Coverage On Alto N...
Benzinga Newsdesk

Thursday, June 20, 2024

Alto Neuroscience Initiates Phase 2 Study Of ...
Benzinga Newsdesk

Tuesday, May 21, 2024

Alto Neuroscience Names Michael Hanley As COO
Benzinga Newsdesk

Tuesday, May 14, 2024

Alto Neuroscience Q1 2024 GAAP EPS $(0.76) Mi...
Benzinga Newsdesk

Tuesday, April 23, 2024

Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In Neuropsychiatry Landscape
Vandana Singh
Alto Neuroscience Announces Phase 1 Results F...
Benzinga Newsdesk

Wednesday, April 03, 2024

Alto Neuroscience Has Initiated Phase 2 Study...
Benzinga Newsdesk

Monday, March 25, 2024

Stifel Reiterates Buy on Alto Neuroscience, M...
Benzinga Newsdesk

Thursday, March 21, 2024

Alto Neuroscience FY23 EPS $(9.73) Down From ...
Benzinga Newsdesk

Tuesday, February 27, 2024

Stifel Initiates Coverage On Alto Neuroscienc...
Benzinga Newsdesk
Jefferies Initiates Coverage On Alto Neurosci...
Benzinga Newsdesk
Baird Initiates Coverage On Alto Neuroscience...
Benzinga Newsdesk

Friday, February 02, 2024

Alto Neuroscience Prices Upsized Initial Publ...
Benzinga Newsdesk

Thursday, February 01, 2024

Alto Neuroscience, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved